Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Impella ECP Early Feasibility Study

NCT: NCT04477603 · ACTIVE_NOT_RECRUITING

NCT IDNCT04477603
StatusACTIVE_NOT_RECRUITING
Start Date2020-10-09
Completion2026-10-31

Brief Summary

The Impella ECP EFS is a prospective, multicenter, single-arm, feasibility study evaluating the safety of the Impella ECP device in adult patients undergoing an elective or urgent high-risk percutaneous coronary intervention.

Frequently Asked Questions

What is Impella ECP Early Feasibility Study?

Impella ECP Early Feasibility Study is a clinical trial registered under NCT04477603. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04477603?

The current status of NCT04477603 (Impella ECP Early Feasibility Study) is: ACTIVE_NOT_RECRUITING.

When did Impella ECP Early Feasibility Study start?

Impella ECP Early Feasibility Study started on 2020-10-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.